PHAR Pharming Group N.V.
$12.26▲ +3.29%
Healthcare
Other
Volume 29.0K
Avg Volume (10D) 16.1K
Key Metrics & Fundamentals
Market Cap
$867.74M
P/E Ratio
38.3
Div Yield
0.00%
52W Range
9.11 - 21.34
% vs 50 MA
14.62%
% vs 200 MA
-11.44%
RSI-14
71.6
MACD Histogram
+0.3600
Beta (1Y vs SPY)
1.00
Free Cash Flow
-$9.74M
Gross Rev
$90.21M
Gross Profit
$75.67M
EBITDA
$8.75M
COGS
$14.55M
Operating Exp
$75.78M
Operating Income
-$111,000
EBIT
-$111,000
Pretax Income
$3.04M
Net Income
$1.64M
Price & Volume History
Loading chart…
Recent News
Pharming Group (PHGUF) Q3 2026 Earnings Call Highlights: Revenue Jumps 21% as Rucanest Rebounds ...
GuruFocus.com · Oct 28, 2026 11:01 AM ET
Pharming Group (ENXTAM:PHARM) Stock Faces A Q3 Earnings Valuation Gap
Simply Wall St. · Oct 28, 2026 1:17 AM ET
Pharming (PHAR) Q3 2026 Earnings Call Transcript
Motley Fool · Oct 27, 2026 1:30 PM ET
Pharming Group Q3 Earnings Call Highlights
MarketBeat · Oct 27, 2026 11:05 AM ET
Pharming Q3 Earnings, Revenue Increase
MT Newswires · Oct 27, 2026 4:13 AM ET
Pharming Group reports third quarter 2026 financial results; strong revenue growth, Joenja APDS expansion and CVID topline data in November
GlobeNewswire · Oct 27, 2026 2:00 AM ET
Pharming Group announces third quarter 2026 revenues above market expectations
GlobeNewswire · Oct 22, 2026 1:00 AM ET
Pharming presents positive Phase II topline data for leniolisib in genetic PIDs with immune dysregulation at ESID 2026
GlobeNewswire · Oct 14, 2026 2:00 AM ET
Sector Update: Healthcare Stocks Advance Pre-Bell Tuesday
MT Newswires · Sep 29, 2026 9:24 AM ET
Pharming Appoints Leverne Marsh, Kenneth Lynard as Co-CEOs
MT Newswires · Sep 29, 2026 3:37 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See PHAR's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.